1. Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis. Tavori H, Giunzioni I, Linton MF, Fazio S (2013) Circ Res 113(12): 1290-5
    › Primary publication · 24122718 (PubMed) · PMC3939022 (PubMed Central)
  2. Killing two birds with one stone, maybe: CETP inhibition increases both high-density lipoprotein levels and insulin secretion. Fazio S, Linton MF (2013) Circ Res 113(2): 94-6
    › Primary publication · 23833288 (PubMed) · PMC3953452 (PubMed Central)
  3. Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus. Ormseth MJ, Swift LL, Fazio S, Linton MF, Raggi P, Solus JF, Oeser A, Bian A, Gebretsadik T, Shintani A, Stein CM (2013) Lupus 22(1): 26-33
    › Primary publication · 23060481 (PubMed) · PMC3684362 (PubMed Central)
  4. When it looks like familial hypercholesterolemia...but is not. Fazio S, Linton MF (2012) Circ Cardiovasc Genet 5(6): 599-601
    › Primary publication · 23250898 (PubMed)
  5. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Sampson UK, Fazio S, Linton MF (2012) Curr Atheroscler Rep 14(1): 1-10
    › Primary publication · 22102062 (PubMed) · PMC3697085 (PubMed Central)
  6. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men's Health Study. Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, Linton MF, Fazio S, Zheng W, Shu XO (2012) Nutr Metab Cardiovasc Dis 22(5): 409-16
    › Primary publication · 21277179 (PubMed) · PMC3150417 (PubMed Central)
  7. Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistin. Fazio S, Linton MF (2012) J Am Coll Cardiol 59(19): 1706-8
    › Primary publication · 22554601 (PubMed)
  8. Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. Villegas R, Xiang YB, Cai H, Elasy T, Cai Q, Zhang X, Fazio S, Linton MF, Li H, Xu WH, Yang G, Zheng W, Shu XO (2012) Nutr Metab Cardiovasc Dis 22(3): 223-30
    › Primary publication · 21111583 (PubMed) · PMC3143269 (PubMed Central)
  9. Inhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeutics. Fazio S, Linton MF (2012) Arterioscler Thromb Vasc Biol 32(5): 1060-2
    › Primary publication · 22517359 (PubMed)
  10. Evaluation of macrophage-specific promoters using lentiviral delivery in mice. Levin MC, Lidberg U, Jirholt P, Adiels M, Wramstedt A, Gustafsson K, Greaves DR, Li S, Fazio S, Linton MF, Olofsson SO, Borén J, Gjertsson I (2012) Gene Ther 19(11): 1041-7
    › Primary publication · 22130447 (PubMed) · PMC3697098 (PubMed Central)